Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis

Respiratory Medicine - Tập 136 - Trang 111-117 - 2018
Guillermo Suarez-Cuartin1,2, Jordi Giner1,2, José Luis Merino3, Ana Rodrigo-Troyano1,2, Anna Feliu1,2, Lidia Perea2, Ferran Sanchez-Reus2,4, Diego Castillo1,2, Vicente Plaza1,2, James D. Chalmers5, Oriol Sibila1,2
1Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
2Institut d’Investigació Biomédica Sant Pau (IIB Sant Pau), Barcelona, Spain
3Electronic Systems Group, Universitat de les Illes Balears, Palma de Mallorca, Spain
4Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
5Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK

Tài liệu tham khảo

Pasteur, 2010, British Thoracic Society guideline for non-CF bronchiectasis, Thorax, 65, i1, 10.1136/thx.2010.136119 Ringshausen, 2015, Bronchiectasis in Germany: a population-based estimation of disease prevalence, Eur. Respir. J., 46, 1805, 10.1183/13993003.00954-2015 Quint, 2016, Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study, Eur. Respir. J., 47, 186, 10.1183/13993003.01033-2015 Seitz, 2010, Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006, Chest, 138, 944, 10.1378/chest.10-0099 De La Rosa, 2016, Annual direct medical costs of bronchiectasis treatment, Chron. Respir. Dis., 13, 361, 10.1177/1479972316643698 Finch, 2015, A comprehensive analysis of the impact of Pseudomonas aeruginosa colonisation on prognosis in adult bronchiectasis, Ann. Am. Thorac. Soc., 12, 1602 Martínez-García, 2007, Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis, Chest, 132, 1565, 10.1378/chest.07-0490 Lentino, 1987, Nonvalue of sputum culture in the management of lower respiratory tract infections, J. Clin. Microbiol., 25, 758, 10.1128/JCM.25.5.758-762.1987 Aliberti, 2016, Clinical phenotypes in adult patients with bronchiectasis, Eur. Respir. J., 47, 1113, 10.1183/13993003.01899-2015 Hill, 2014, National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care?, Thorax, 69, 292, 10.1136/thoraxjnl-2013-203739 Aliberti, 2016, Quality standards for the management of bronchiectasis in Italy: a national audit, Eur. Respir. J., 48, 244, 10.1183/13993003.00232-2016 Turner, 2004, Innovation: electronic noses and disease diagnostics, Nat. Rev. Microbiol., 2, 161, 10.1038/nrmicro823 Scarlata, 2015, Exhaled breath analysis by electronic nose in respiratory diseases, Expert Rev. Mol. Diagn, 15, 933, 10.1586/14737159.2015.1043895 Fens, 2009, Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma, Am. J. Respir. Crit. Care Med., 180, 1076, 10.1164/rccm.200906-0939OC Dragonieri, 2007, An electronic nose in the discrimination of patients with asthma and controls, J. Allergy Clin. Immunol., 120, 856, 10.1016/j.jaci.2007.05.043 Paff, 2013, Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia, J. Cyst. Fibros., 12, 454, 10.1016/j.jcf.2012.12.010 Sibila, 2014, Identification of airway bacterial colonization by an electronic nose in chronic obstructive pulmonary disease, Respir. Med., 108, 1608, 10.1016/j.rmed.2014.09.008 Shafiek, 2015, Using the electronic nose to identify airway infection during COPD exacerbations, PLoS One, 10, 10.1371/journal.pone.0135199 Scott-Thomas, 2010, 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung, BMC Pulm. Med., 10, 56, 10.1186/1471-2466-10-56 Gilchrist, 2013, Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection, J. Breath Res., 7, 26010, 10.1088/1752-7155/7/2/026010 Gilchrist, 2015, Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis, ERJ Open Res., 1, 10.1183/23120541.00044-2015 Joensen, 2014, Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections, PLoS One, 9, 10.1371/journal.pone.0115584 Lai, 2002, Identification of upper respiratory bacterial pathogens with the electronic nose, Laryngoscope, 112, 975, 10.1097/00005537-200206000-00007 Vendrell, 2008, Diagnóstico y tratamiento de las bronquiectasias, Arch. Bronconeumol., 44, 629, 10.1157/13128330 Chalmers, 2014, The bronchiectasis severity index an international derivation and validation study, Am. J. Respir. Crit. Care Med., 189, 576, 10.1164/rccm.201309-1575OC Martínez-García, 2014, Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score, Eur. Respir. J., 43, 1357, 10.1183/09031936.00026313 Laszlo, 2006, Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force, Thorax, 61, 744, 10.1136/thx.2006.061648 Roca, 1986, Spirometric reference values from a Mediterranean population, Bull. Eur. Physiopathol. Respir., 22, 217 Sibila, 2015, Secreted mucins and airway bacterial colonization in non-CF bronchiectasis, Respirology, 20, 1082, 10.1111/resp.12595 Murray, 1975, Microscopic and baceriologic analysis of expectorated sputum, Mayo Clin. Proc., 50, 339 Plaza, 2015, Inflammatory asthma phenotype discrimination using an electronic nose breath analyzer, J Investig. Allergol. Clin. Immunol., 25, 431 King, 2007, Microbiologic follow-up study in adult bronchiectasis, Respir. Med., 101, 1633, 10.1016/j.rmed.2007.03.009 Chalmers, 2012, Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis, Am. J. Respir. Crit. Care Med., 186, 657, 10.1164/rccm.201203-0487OC Chalmers, 2016, Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis, Am. J. Respir. Crit. Care Med. Schulz, 2007, Bacterial volatiles: the smell of small organisms, Nat. Prod. Rep., 24, 814, 10.1039/b507392h Thorn, 2012, Microbial volatile compounds in health and disease conditions, J. Breath Res., 6, 24001, 10.1088/1752-7155/6/2/024001 Goeminne, 2012, Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis, Respir. Res., 13, 87, 10.1186/1465-9921-13-87 Lonni, 2015, Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity, Ann. Am. Thorac. Soc., 12, 1764, 10.1513/AnnalsATS.201507-472OC McDonnell, 2016, Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study, Lancet Respir. Med, 4, 969, 10.1016/S2213-2600(16)30320-4 Angrill, 2002, Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors, Thorax, 57, 15, 10.1136/thorax.57.1.15